Maximus, Inc.

Here are three stocks with buy rank and strong income characteristics for investors to consider today, Oct. 22:
Universal Insurance Holdings, Inc. UVE: This insurance holding company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 63.8% over the last 60 days.
UNIVERSAL INSURANCE HOLDINGS INC Price and Consensus
This Zacks Rank #1 company has a dividend yield of 2.2%, compared with the industry average of 0.7%.
UNIVERSAL INSURANCE HOLDINGS INC Dividend Yield (TTM)
UNIVERSAL INSURANCE HOLDINGS INC dividend-yield-ttm | UNIVERSAL INSURANCE HOLDINGS INC Quote
Gold Fields Limited GFI: This gold producer has witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.7% over the last 60 days.
Gold Fields Limited Price and Consensus
This Zacks Rank #1 company has a dividend yield of 1.5%, compared with the industry average of 0.0%.
Gold Fields Limited Dividend Yield (TTM)
Maximus, Inc. MMS: This business process services provider to the public sector has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6% over the last 60 days.
Maximus, Inc. Price and Consensus
This Zacks Rank #1 company has a dividend yield of 1.4%, compared with the industry average of 0.6%.
Maximus, Inc. Dividend Yield (TTM)
See the full list of top ranked stocks here.
Find more top income stocks with some of our great premium screens.
Beyond Nvidia: AI's Second Wave Is Here
The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. Little-known AI firms tackling the world's biggest problems may be more lucrative in the coming months and years.
See "2nd Wave" AI stocks now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Best Income Stocks to Buy for Oct. 22

For Immediate Release
Chicago, IL – October 7, 2025 – Stocks in this week’s article are Maximus MMS, Pediatrix Medical Group, Inc. MD, Sally Beauty SBH and State Street STT.
4 Stocks Trading Near 52-Week Highs with Room to Rise Further
Stocks hitting their 52-week high and delivering consistent performance offer attractive opportunities to investors while building a portfolio. This is because stocks near that level are perceived to be winners. However, stocks touching a new 52-week high are often predisposed to profit-taking, resulting in pullbacks and trend reversals.
Moreover, given the high price, investors often wonder if the stock is overpriced. While the speculations are not absolutely baseless, all stocks hitting a 52-week high are not necessarily overpriced.
In fact, investors might lose out on top gainers in an attempt to avoid the steep prices.
Stocks such as Maximus, Pediatrix Medical Group, Inc., Sally Beauty and State Street are expected to maintain their momentum and keep scaling new highs. Extensive information on a stock is necessary to understand whether or not there is scope for further upside.
Here, we discuss a strategy to find the right stocks. The strategy borrows from the basics of momentum investing. This technique bets on "buy high, sell higher."
52-Week High: A Good Indicator
Many times, stocks that hit a 52-week high fail to scale higher despite having potential. This is because investors fear that the stocks are overvalued and expect the price to crash.
In fact, overvaluation is natural for most of these stocks as investors' focus (or willingness to pay a premium) has helped them reach the level. But that does not always indicate an impending decline. Factors such as robust sales, surging profit levels, earnings growth prospects and strategic acquisitions that encourage investors to bet on these stocks could keep them motivated if there is no tangible negative. In other words, the momentum might continue.
Also, when a string of positive developments dominates the market, investors find their underreaction unwarranted, even if there are no company-specific driving forces.
Here are four stocks, each sporting a Zacks Rank #1, out of the 13 that made it through the screen:
Maximus has built a strong reputation as a trusted partner to governments worldwide, with over four decades of expertise, delivering cost-effective, scalable solutions in health and human services. Long-term contracts, steady dividend payouts, and its ability to adapt to complex social needs, expand into clinical services, and leverage a skilled workforce give it a competitive edge.
Maximus is enhancing its competitive edge with the achievement of CMMC Level 2 certification. This demonstrates its ability to meet strict Department of Defense cybersecurity standards, safeguard sensitive defense data and accelerate program launches by bypassing lengthy Authorization to Operate delays. This milestone reinforces Maximus' position as a trusted partner for defense and national security missions.
The Zacks Consensus Estimate for MMS's fiscal 2025 earnings has moved north by 3.3% to $6.95 per share in the past 30 days. The company surpassed the Zacks Consensus Estimate in the trailing four quarters, the average surprise being 21.43%.
Pediatrix Medical's top line has been benefiting from strong same-unit revenue gains, improved neonatology patient volumes, stable payor mix and higher hospital contract administrative fees. It is boosting service offerings across maternal-fetal medicine, neonatology and obstetrics. The company projects adjusted EBITDA to be within $245-$255 million in 2025. It remains focused on streamlining its portfolio by divesting non-core assets, allowing it to sharpen its focus on high-margin core services.
MD has a strong pipeline of future acquisitions and continued expansion of specialty care services. It projects net income to be within the range of $126.02-$133.32 million for 2025. It is expanding telehealth services to provide more accessible and affordable healthcare.
The Zacks Consensus Estimate for MD's 2025 earnings has remained steady at $1.78 per share in the past 30 days. The company surpassed the Zacks Consensus Estimate in the trailing four quarters, the average surprise being 28.74%.
Sally Beauty continues to advance its strategic priorities, focusing on customer engagement, high-margin owned brands and innovation. The company is undergoing a brand refresh, modernizing its identity and enhancing its digital presence and in-store experience to strengthen its position in the beauty industry. The expansion of its marketplace partnerships and loyalty program is driving customer retention and sales growth, while investments in exclusive brands and product innovation support long-term success.
The Fuel for Growth program holds the key to cost savings and margin expansion through operational efficiencies. For fiscal 2025, comparable sales are now projected to remain flat compared with the previous guidance of flat to a 1% decline year over year. The company now expects its adjusted operating margin within the range of 8.6-8.7% compared with the earlier guided band of 8-8.5% for fiscal 2025.
The Zacks Consensus Estimate for SBH's fiscal 2025 earnings has remained steady at $1.84 per share in the past 30 days. The company surpassed the Zacks Consensus Estimate in the trailing four quarters, the average surprise being 8.32%.
State Street provides a range of products and services for institutional investors worldwide through its subsidiaries. Solid business servicing wins, a global footprint, and strategic acquisitions and collaborations will continue to support fee income growth. We expect fee revenues to record a CAGR of 4.6% over the next three years. Higher interest rates will aid net interest income (NII) growth. We expect NII to witness a CAGR of 1.4% by 2027. Rising assets under management (AUM) balance will drive financials. Our estimates for total AUM imply a CAGR of 14.9% by 2027.
STT is teaming up with Apex Fintech Solutions in a move that signals its ambition to transform the wealth management infrastructure. Through this collaboration, STT will integrate Apex's custody and clearing technology with its institutional-grade infrastructure and global client network. The result will be a differentiated solution that allows wealth managers, fintech platforms and advisors to launch and scale wealth services more efficiently while providing a seamless end-client experience.
The Zacks Consensus Estimate for STT's 2025 earnings has moved north by 0.9% to $9.94 per share in the past 30 days. The company surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 6.58%.
Get the rest of the stocks on the list and start putting this and other ideas to the test. It can all be done with the Research Wizard stock picking and back-testing software.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your trial to the Research Wizard today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2762744/4-stocks-trading-near-52-week-high-with-room-to-rise-further
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
About Screen of the Week
Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Visit: https://www.zacks.com/
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in the coming year. While not all picks can be winners, previous recommendations have soared +112%, +171%, +209% and +232%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Zacks.com featured highlights include Maximus, Pediatrix Medical, Sally Beauty and State Street

The Board of Directors of Caterpillar voted to maintain the quarterly dividend of one dollar and fifty-one cents per share of common stock payable Nov. 20 to shareholders of record at the close of business Oct. 20. Caterpillar has paid a cash dividend every year since the company was formed and has paid a quarterly dividend since 1933. With this dividend payment, Caterpillar will have paid higher annual dividends to shareholders for 32 consecutive years and is recognized as a member of the S&P 500 Dividend Aristocrats Index.
Maximus, a leading provider of government services, announced on October 6, 2025, that its Board of Directors has approved a quarterly cash dividend of $0.30 per share, payable on December 1, 2025, to shareholders of record on November 14, 2025.
Franklin Street Properties announced today that its Board of Directors declared a quarterly dividend of $0.01 per share of common stock for the period July 1, 2025 through September 30, 2025, payable on November 6, 2025 to stockholders of record as of October 17, 2025.
MV Oil Trust announced the Trust distribution of net profits for the quarterly payment period ended September 30, 2025. Unitholders of record on October 15, 2025 will receive a distribution amounting to $2,357,500 or $0.205 per unit payable October 24, 2025.
VIDEO: Daily Dividend Report: CAT,MMS,FSP,MVO
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Daily Dividend Report: CAT,MMS,FSP,MVO

Markets started 2025 on a positive note but have since faced considerable volatility. Tariff-related headwinds and geopolitical uncertainty persist, yet the Federal Reserve’s interest rate cut signals a softening labor market and the inflationary effects of trade policies. The central bank hinted at two more rate cuts before the year's end. Given this macroeconomic backdrop, choosing the correct stocks remains challenging for retail investors.
Therefore, sales growth provides a more dependable lens for evaluating stocks than traditional earnings-focused metrics. Hence, stocks such as Universal Health Services Inc. UHS, Methanex Corporation MEOH, Arista Networks, Inc. ANET, Voya Financial Inc. VOYA and Maximus, Inc. MMS are worth considering for investment.
When evaluating a company, sales growth is often given a preference over earnings. Consistent sales growth reflects the actual demand for a company’s products or services. Focusing on sales also offers investors greater visibility into the durability of a company’s business model. The company that can expand its top line during periods of economic stress signals pricing power, competitive advantages and the ability to capture market share.
On the other hand, earnings can be distorted by one-off charges, cost-cutting, accounting adjustments or temporary margin expansions, making them less indicative of a company’s underlying trajectory.
Moreover, sustained sales growth often translates into stronger and more predictable cash flows, providing management with the financial flexibility to reinvest in innovation, expand into new markets or return capital to shareholders, all without excessive reliance on debt. Robust cash reserves and steady cash flow provide companies with the flexibility to weather challenges, pursue growth opportunities and sustain operational stability even in uncertain conditions.
Selecting the Potential Winning Stocks
To shortlist stocks with impressive sales growth and a high cash balance, we have selected 5-Year Historical Sales Growth (%) greater than X-Industry and Cash Flow of more than $500 million as our main screening parameters.
But sales growth and cash strength are not the absolute criteria for selecting stocks. Hence, we have added other factors to arrive at a winning strategy.
P/S Ratio less than X-Industry: This metric determines the value placed on each dollar of a company’s revenues. The lower the ratio, the better it is for picking a stock since the investor is paying less for each unit of sales.
% Change F1 Sales Estimate Revisions (four weeks) greater than X-Industry: Estimate revisions, better than the industry, are often seen to trigger an increase in stock price.
Operating Margin (average last five years) greater than 5%: Operating margin measures how much every dollar of a company's sales translates into profits. A high ratio indicates that the company has good cost control and sales are increasing faster than costs — an optimal situation.
Return on Equity (ROE) greater than 5%: This metric will ensure that sales growth is translated into profits and the company is not hoarding cash. A high ROE means that the company is spending wisely and is in all likelihood profitable.
Zacks Rank less than or equal to 2: Zacks Rank #1 (Strong Buy) or 2 (Buy) stocks are known to outperform, irrespective of the market environment. You can see the complete list of today’s Zacks #1 Rank stocks here.
5 Stocks With Attractive Sales Growth to Buy
King of Prussia, PA-based Universal Health Services owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers. UHS operates more than 350 inpatient acute care hospitals and 60 outpatient and other facilities across 39 states, Washington, DC, the United Kingdom and Puerto Rico.
UHS’ expected sales growth rate for 2025 is 8.5%. Universal Health Services carries a Zacks Rank #2 at present.
Methanex, headquartered in Vancouver, Canada, is a leading global supplier of methanol. MEOH has production sites in New Zealand, the United States, Trinidad and Tobago, Egypt, Canada and Chile.
Methanex’s expected sales growth rate for 2025 is 5.6%. PGR currently sports a Zacks Rank #1.
Headquartered in Santa Clara, CA, Arista provides cloud networking solutions for data centers and cloud computing environments. At the core of ANET’s cloud networking solutions is the Linux-based Extensible Operating System.
Arista’s sales are expected to jump 25.4% in 2025. ANET carries a Zacks Rank #2 at present.
Based in New York, Voya Financial operates as a retirement, investment and employee benefits company. VOYA offers products and services through financial intermediaries, independent producers, affiliated advisors and dedicated sales specialists.
Voya Financial’s expected sales growth for 2025 is 16.1%. VOYA, at present, carries a Zacks Rank #2.
Reston, VA-based Maximus operates government health and human services programs globally. MMS has built a strong reputation as a trusted partner to governments worldwide, delivering cost-effective, scalable solutions in health and human services.
Maximus’ sales are expected to grow 2.7% in fiscal 2025. MMS sports a Zacks Rank #1 at present.
Get the remaining stock on the list and start putting this and other ideas to the test. It can all be done with the Research Wizard stock picking and backtesting software.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Click here to sign up for a free trial of the Research Wizard today.
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
Disclosure: Performance information for Zacks’ portfolios and strategies are available at:https://www.zacks.com/performance
Higher. Faster. Sooner. Buy These Stocks Now
A small number of stocks are primed for a breakout, and you have a chance to get in before they take off.
At any given time, there are only 220 Zacks Rank #1 Strong Buys. On average, this list more than doubles the S&P 500. We’ve combed through the latest Strong Buys and selected 7 compelling companies likely to jump sooner and climb higher than any other stock you could buy this month.
You'll learn everything you need to know about these exciting trades in our brand-new Special Report, 7 Best Stocks for the Next 30 Days.
Download the report free now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

5 Stocks With Robust Sales Growth to Overcome Macro Challenges

(RTTNews) - Maximus (MMS) has expanded its common stock repurchase program to a total of $400 million, which includes $32.7 million remaining under its prior program.
The company will buy back shares through open market purchases, 10b5-1 plans, or private transactions, depending on market conditions and corporate needs. The program has no set expiration date and can be modified or suspended at any time.
CEO Bruce Caswell said the move reflects Maximus' sustained momentum, commitment to disciplined capital allocation, and focus on returning value to shareholders while funding strategic growth initiatives. Since June 30, 2025, Maximus has repurchased 375,898 shares for about $31.6 million.
Wednesday MMS closed at $87.60, up 0.21%, with no after-hours movement on the NYSE.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Maximus Expands Stock Repurchase Program To $400 Mln

The Interpublic Group of Companies IPG is an advertising and marketing service provider across the globe that has performed extremely well over the past three months and has the potential to sustain momentum in the near term. If you have not taken advantage of the share price appreciation yet, you should add the stock to your portfolio now.
What Makes IPG an Attractive Pick?
An Outperformer: A glimpse at the company’s price trend reveals that the stock has had an impressive run over the past three months. Shares of IPG have returned 14.6%, outperforming the 1.8% decline of the industry and the S&P 500’s 8.9% rise.
Image Source: Zacks Investment Research
Solid Rank: IPG sports a Zacks Rank #1 (Strong Buy) and has a VGM Score of B at present. Our research shows that stocks with a VGM Score of A or B, when combined with a Zacks Rank #1 or 2 (Buy), offer the best investment opportunities for investors. Thus, the company appears to be a compelling investment proposition at the moment.
Strong Growth Prospects: The Zacks Consensus Estimate for Interpublic Group of Companies’ 2025 earnings is pegged at $2.88 per share, implying 4% year-over-year growth. The consensus estimate for 2026 earnings stands at $3.05 per share, hinting at a 5.9% year-over-year increase.
Growth Factors: Interpublic is driven by its marketing strategies, as evidenced by its partnership with Aaru in August to integrate AI-powered predictive simulations into campaign planning and execution. By combining Aaru’s advanced technology with Acxiom’s data capabilities and the Interact platform, Interpublic can forecast audience sentiment, refine creative assets and optimize performance before launch. This strategic move enables real-time insights, faster decision-making and highly targeted campaigns at scale, all while maintaining a strong commitment to ethical data practices and maximizing ROI for clients.
The company’s launch of Agentic Systems for Commerce (“ASC”) in July 2025 marks a significant step in leveraging AI and automation to help brands navigate the complexities of modern commerce. By integrating Intelligence Node’s real-time data capabilities with Interpublic’s proprietary agentic system, ASC enables brands to optimize pricing, inventory and digital shelf performance across channels with speed and precision. Early adoption by more than 20 CPG brands and double-digit sales improvements highlight its potential to drive measurable business outcomes while expanding Interpublic’s solutions beyond traditional marketing into AI-powered commerce optimization.
Moreover, IPG remains attractive to dividend-seeking investors, underscoring its commitment to delivering consistent shareholder value. The company paid dividends of $496.5 million in 2024, $479.1 million in 2023 and $457.3 million in 2022, reflecting a steady increase over the years. During the first half of 2025 alone, total dividend payouts amounted to $246.4 million, reinforcing IPG’s dedication to rewarding investors and boosting confidence in its long-term financial stability.
Other Stocks to Consider
Some other top-ranked stocks from the broader Zacks Business Services sector are Maximus MMS and AppLovin APP
Maximus sports a Zacks Rank of #1 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
MMS has an encouraging earnings surprise history, having outpaced the Zacks Consensus Estimate in three of the trailing four quarters and missing once. The average beat is 29.3%.
AppLovin also sports a Zacks Rank of 1.
APP has an encouraging earnings surprise history, outperforming the Zacks Consensus Estimate in each of the trailing four quarters. The average beat is 22.36%.
Higher. Faster. Sooner. Buy These Stocks Now
A small number of stocks are primed for a breakout, and you have a chance to get in before they take off.
At any given time, there are only 220 Zacks Rank #1 Strong Buys. On average, this list more than doubles the S&P 500. We’ve combed through the latest Strong Buys and selected 7 compelling companies likely to jump sooner and climb higher than any other stock you could buy this month.
You'll learn everything you need to know about these exciting trades in our brand-new Special Report, 7 Best Stocks for the Next 30 Days.
Download the report free now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Here's Why Interpublic Group Stock Is a Great Pick At Present

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares Dow Jones U.S. ETF (Symbol: IYY), we found that the implied analyst target price for the ETF based upon its underlying holdings is $172.57 per unit.
With IYY trading at a recent price near $157.45 per unit, that means that analysts see 9.60% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of IYY's underlying holdings with notable upside to their analyst target prices are ASGN Inc (Symbol: ASGN), MAXIMUS Inc. (Symbol: MMS), and MDU Resources Group Inc (Symbol: MDU). Although ASGN has traded at a recent price of $52.10/share, the average analyst target is 20.37% higher at $62.71/share. Similarly, MMS has 19.12% upside from the recent share price of $85.63 if the average analyst target price of $102.00/share is reached, and analysts on average are expecting MDU to reach a target price of $19.50/share, which is 15.45% above the recent price of $16.89. Below is a twelve month price history chart comparing the stock performance of ASGN, MMS, and MDU:
Below is a summary table of the current analyst target prices discussed above:
Name
Symbol
Recent Price
Avg. Analyst 12-Mo. Target
% Upside to Target
iShares Dow Jones U.S. ETF
IYY
$157.45
$172.57
9.60%
ASGN Inc
ASGN
$52.10
$62.71
20.37%
MAXIMUS Inc.
MMS
$85.63
$102.00
19.12%
MDU Resources Group Inc
MDU
$16.89
$19.50
15.45%
Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Add Up The Parts: IYY Could Be Worth $173

Maximus, Inc. MMS reported impressive third-quarter fiscal 2025 results. Both earnings and revenues beat the Zacks Consensus Estimate. The better-than-expected results positively impacted the market as the stock has rallied 4% since the earnings release.
Image Source: Zacks Investment Research
Quarterly adjusted earnings of $2.16 per share beat the Zacks Consensus Estimate by 55.4% and increased 24.1% year over year. Revenues of $1.35 billion topped the consensus mark by 4.5% and rose 2.6% from the year-ago quarter.
Maximus, Inc. Price, Consensus and EPS Surprise
Maximus raised the earnings and revenue guidance for fiscal year 2025. Total revenues are now expected between $5.38 billion and $5.48 billion compared with the previous expectation of $5.25 billion and $5.34 billion. The Zacks Consensus Estimate is pegged at $5.38 billion.
Adjusted earnings are anticipated in the range of $7.35-$7.55 per share compared with the previous expectations of $6.30-$6.60 per share. The updated guided range is higher than the current Zacks Consensus Estimate of $6.61.
Segmental Revenues of Maximus
The U.S. Federal Services segment’s revenues of $761.2 million rose 11.4% from the year-ago reported number and beat our estimate of $686.8 million. Meanwhile, the Outside the U.S. segment’s revenues of $147.4 million decreased 6.9% year over year and missed our anticipation of $163.7 million. The U.S. Services segment’s revenues of $439.8 million fell 6.9% year over year and lagged our estimate of $440.2 million.
MMS’ Sales and Pipeline
Year-to-date signed contract awards, as of June 30, 2025, totaled $3.37 billion. Contracts pending (awarded but unsigned) amounted to $1.44 billion. The sales pipeline, as of June 30, was $44.7 billion. This included $3.05 billion in pending proposals, $1.20 billion in proposals in preparation and $40.4 billion in opportunities tracking. The book-to-bill ratio was 0.8 on a trailing 12-month basis.
MMS’ Operating Performance
Operating income of $165.7 million increased 16.9% year over year. This compares with our expected adjusted operating income of $128 million, down 22.6% year over year. The adjusted operating income margin of 12.3% increased 151 basis points year over year.
Maximus’ Balance Sheet and Cash Flow
Maximus ended the quarter with a cash and cash equivalent balance of $59.8 million compared with $73 million reported at the end of the prior quarter.
The company generated $182.7 million in cash from operations. Free cash outflow was $198.2 million.
MMS Updates Fiscal 2025 Guidance
The company expects an adjusted EBITDA margin of approximately 13% compared with 11.7% expected earlier.
Free cash flow expectation is between $370 million and $390 million. The company forecasts interest expenses of approximately $81 million compared with the prior anticipation of $78 million. The effective income tax rate is anticipated to be within 28-29%. On a full-year basis, the weighted average shares outstanding are forecasted to be approximately 58 million.
Currently, Maximus carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Earnings Snapshot
Fiserv, Inc. FI reported mixed second-quarter 2025 results, wherein earnings beat the Zacks Consensus Estimate, but revenues missed the same.
FI’s adjusted EPS of $2.47 topped the consensus mark by 2.5% and rose 16% year over year. Adjusted revenues of $5.2 billion lagged the consensus estimate by a slight margin but gained 1.7% on a year-over-year basis.
The Interpublic Group of Companies, Inc. IPG reported impressive second-quarter 2025 results. Both earnings and revenues beat the Zacks Consensus Estimate.
IPG’s adjusted earnings of 75 cents per share surpassed the Zacks Consensus Estimate by 36.4% and jumped 23% from the year-ago quarter. Revenues before billable expenses (net revenues) of $2.2 billion beat the consensus estimate by a slight margin but declined 19.8% year over year. Total revenues of $2.5 billion decreased 7.2% year over year but outpaced the Zacks Consensus Estimate of $2.2 billion.
See our %%CTA_TEXT%% report – free today!
7 Best Stocks for the Next 30 Days
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Maximus' Q3 Earnings Beat Estimates, Stock Rallies 4%

(RTTNews) - Maximus Inc (MMS), a provider of government services, Monday announced that it has won a $77 million contract from the U.S. Air Force Life Cycle Management Center's Cryptologic and Cyber Systems Division.
Over an initial one-year term with four one-year options and a six-month extension, Maximus will deliver advanced cybersecurity, cloud computing, and engineering support across multiple security domains for the Department of Defense.
MMS is currently trading at $72.57, down $0.87 or 1.19 percent on the New York Stock Exchange.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Maximus Secures $77 Mln U.S. Air Force Cybersecurity And Cloud Services Contract

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.
On Wednesday, Conduent's Director, Harshavardhan V. Agadi, made a $281,000 purchase of CNDT, buying 100,000 shares at a cost of $2.81 a piece. Bargain hunters can snag CNDT even cheaper than Agadi did, with the stock changing hands as low as $2.61 in trading on Friday which is 7.1% below Agadi's purchase price. Conduent is trading up about 1.7% on the day Friday.
And on Monday, Raymond B. Ruddy bought $99,962 worth of MAXIMUS, buying 1,435 shares at a cost of $69.66 each. Before this latest buy, Ruddy made one other purchase in the past year, buying $249,395 shares for a cost of $71.46 each. MAXIMUS is trading down about 2.7% on the day Friday. Bargain hunters are able to pick up MMS at a price even lower than Ruddy did, with the stock changing hands as low as $67.25 at last check today which is 3.5% under Ruddy's purchase price.
VIDEO: Friday 6/20 Insider Buying Report: CNDT, MMS
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Maximus, Inc.

Trend

Trend Class

Trend Power

Pattern

EMA

EMA-20

EMA-50

EMA-100

EMA-20

EMA-50

EMA-100

Oscillators

Stochastic

RSI

MACD

Candle pattern type